Insulet | PODD - Operating Expenses

Stock Price
189.56
Daily Change
-2.65 -1.38%
Monthly
-12.24%
Yearly
-27.29%
Q2 Forecast
185.50

Insulet reported $637.5M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Abbott USD 9.31B 104M Mar/2026
Align Technology USD 822.85M 11.8M Dec/2025
AtriCure USD 138.01M 3.95M Dec/2025
Avanos Medical USD 156.13M 2.7M Dec/2025
Baxter International USD 3.19B 554.4M Dec/2025
Becton, Dickinson and Co. USD 4.59B 476M Dec/2025
Boston Scientific USD 4.04B 18M Dec/2025
Cardinal Health USD -2.88B 5M Dec/2025
Cooper Companies USD 811.3M 113.5M Dec/2025
Dexcom USD 936.6M 30.2M Dec/2025
Edwards Lifesciences USD 1.13B 65.4M Mar/2026
Eli Lilly USD 10.31B 1.09B Dec/2025
Globus Medical USD 645.11M 241.46M Dec/2025
ICU Medical USD 514.62M 4.48M Dec/2025
Inogen USD 49.14M 665K Sep/2024
Insulet USD 637.5M 48.9M Dec/2025
Integra LifeSciences USD 368.92M 668.65M Dec/2025
J&J USD 17.44B 1.53B Mar/2026
Masimo USD 328.6M 181.6M Dec/2025
Medtronic USD 7.28B 16M Dec/2025
Merit Medical Systems USD 339.74M 1.8M Dec/2025
Roche Holding CHF 21.01B 10.84B Dec/2025
Solventum Corp USD 1.89B 3.09B Dec/2025
Stryker USD 5.2B 505M Dec/2025
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 532.64M 3.29B Dec/2025
West Pharmaceutical Services USD 2.99B 2.35B Mar/2026
Zimmer Biomet Holdings USD 1.94B 277.8M Dec/2025